University Medical Centre Hamburg-Eppendorf, Centre of Oncology

Hamburg 20251

1 studies enrolling now · 5 studies all time

What they study most

CRC (Colorectal Cancer), Chronic Graft Versus Host Disease, Chronic Graft-versus-host Disease, Myelofibrosis, Postlung Transplant (Bronchiolitis Obliterans), Solid Tumor Malignancy, Squamous Cell Carcinoma of Anal Canal

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer — Recruiting now
• A Rollover Study to Provide Continued Treatment for Participants Previously Enrolled in Studies of Itacitinib — Stopped early
• Efficacy and Safety of Pemigatinib in Previously Treated Locally Advanced/Metastatic or Surgically Unresectable Solid Tumor Malignancies Harboring Activating FGFR Mutations or Translocations (FIGHT-207) — Stopped early
• GRAVITAS-309: Itacitinib and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease — Stopped early
• A Study of INCMGA00012 in Squamous Carcinoma of the Anal Canal Following Platinum-Based Chemotherapy (POD1UM-202) — Completed